文献速递肝病

SWAP70通过抑制TAK1保护非酒精性脂肪性肝病

Switch-associated protein 70 protects against nonalcoholic fatty liver disease through suppression of TAK1.
PubMed 文献 · Hepatology · 2022-04-25

本研究探讨SWAP70在NAFLD中的作用及机制。在代谢刺激后小鼠和肝细胞中SWAP70表达显著升高;肝细胞过表达SWAP70抑制脂质沉积和炎症,敲低则相反。肝细胞特异性Swap70敲除和过表达小鼠喂食高脂高胆固醇饮食证实SWAP70通过抑制脂质积累、炎症反应和纤维化来抑制NASH进展。机制上SWAP70抑制TAK1结合蛋白1与TAK1的相互作用,进而抑制TAK1磷酸化及下游JNK/P38信号。

要点

  • SWAP70在代谢刺激后表达升高,过表达可抑制肝细胞脂质沉积和炎症。
  • 肝细胞特异性SWAP70抑制NASH进展中的脂质积累、炎症和纤维化。
  • SWAP70通过阻断TAK1结合蛋白1与TAK1结合抑制TAK1/JNK/P38通路。

核心结论

  • SWAP70是抑制NAFLD进展的保护性分子,可抑制肝脏脂肪变性和炎症。

研究设计与样本

  • 采用小鼠和肝细胞实验,包括肝细胞特异性Swap70敲除和过表达小鼠喂食高脂高胆固醇饮食。

主要发现

  • 代谢刺激后小鼠和肝细胞中SWAP70表达显著升高。
  • 肝细胞过表达SWAP70抑制脂质沉积和炎症,敲低则产生相反效果。
  • 肝细胞特异性Swap70敲除和过表达小鼠证实SWAP70抑制NASH进展中的脂质积累、炎症反应和纤维化。
  • RNA测序和免疫沉淀显示SWAP70抑制TAK1结合蛋白1与TAK1的相互作用,抑制TAK1磷酸化及下游JNK/P38信号。
  • 抑制TAK1激活可阻断SWAP70敲低导致的肝细胞脂质沉积和炎症。

临床怎么用

  • SWAP70可能成为缓解NAFLD进展的潜在干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: NAFLD is a progressive disease without known effective drug treatments. Switch-associated protein 70 (SWAP70) is a guanine nucleotide exchange factor that participates in the regulation of many cellular processes. However, the role of SWAP70 in NAFLD remains unclear. This study aimed to identify the function and mechanism of SWAP70 in NAFLD. APPROACH AND RESULTS: The results showed that the expression of SWAP70 was significantly increased in mice and hepatocytes after metabolic stimulation. Overexpression of SWAP70 in hepatocytes suppressed lipid deposition and inflammation, and SWAP70 knockdown created the inverse effect. Using hepatocyte-specific Swap70 knockout and overexpression mice fed a high-fat, high-cholesterol diet, we demonstrated that SWAP70 suppressed the progression of nonalcoholic steatohepatitis by inhibiting lipid accumulation, inflammatory response, and fibrosis. Mechanically, RNA sequencing analysis and immunoprecipitation assays revealed that SWAP70 inhibited the interaction between transforming growth factor β-activated kinase 1 (TAK1) binding protein 1 and TAK1 and sequentially suppressed the phosphorylation of TAK1 and subsequent c-Jun N-terminal kinase/P38 signaling. Inhibition of TAK1 activation blocked hepatocyte lipid deposition and inflammation caused by SWAP70 knockdown. CONCLUSIONS: SWAP70 is a protective molecule that can suppress the progression of NAFLD by inhibiting hepatic steatosis and inflammation. SWAP70 may be important for mitigating the progression of NAFLD.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Qian Q, Li Y, Fu J, et al. Switch-associated protein 70 protects against nonalcoholic fatty liver disease through suppression of TAK1. Hepatology. 2022. PMID: 34689362. doi:10.1002/hep.32213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。